Toxoplasmic Encephalitis in Patients with Pyrimethamine-Sulfadiazine for Therapy of Trimethoprim-Sulfamethoxazole versus Randomized Trial of

Abstractsof the Seventh International Conference on AIDS.14. Leport, C., F. Raffi, S. Matheron, C. Katlama, B. Regnier, A. G. Saimot, C.Marche, C. Vedrenne, and J. L. Vilde. 1988. Treatment of central nervoussystem toxoplasmosis with pyrimethamine-sulfadiazine combination in 35patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous treatment. Am. J. Med. 84: 94–100.15. Levy, R. M., D. E. Bredesen, and M. L. Rosenblum. 1985. Neurologicalmanifestation of the acquired immunodeficiency syndrome (AIDS): experi-ence at UCSF and review of literature. J. Neurosurg. 62: 475–495.16. Luft, B. J., and J. S. Remington. 1988. Toxoplasmic encephalitis. J. Infect.Dis. 157: 1–6.17. Luft, B. J., and J. S. Remington. 1992. Toxoplasmic encephalitis in AIDS.Clin. Infect. Dis. 15: 211–222.18. Michelet, C., F. Raffi, J. M. Besnier, J. M. Chennebault, F. Moulichon,B. Milpied, J. P. Breux, and F. Cartier. 1992. Cotrimoxazole (CMX) versusaerosolized pentamidine (AP) for primary prophylaxis of Pneumocystis ca-rinii (PCP), abstr. B:139.